GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Allied Healthcare Products Inc (OTCPK:AHPIQ) » Definitions » Beneish M-Score

Allied Healthcare Products (Allied Healthcare Products) Beneish M-Score

: 0.00 (As of Today)
View and export this data going back to 1992. Start your Free Trial

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

The historical rank and industry rank for Allied Healthcare Products's Beneish M-Score or its related term are showing as below:

During the past 13 years, the highest Beneish M-Score of Allied Healthcare Products was 0.00. The lowest was 0.00. And the median was 0.00.


Allied Healthcare Products Beneish M-Score Historical Data

The historical data trend for Allied Healthcare Products's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allied Healthcare Products Annual Data
Trend Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22
Beneish M-Score
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.82 -3.45 -3.80 -1.02 -2.56

Allied Healthcare Products Quarterly Data
Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22
Beneish M-Score Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.02 -1.97 -2.24 -2.38 -2.56

Competitive Comparison

For the Medical Devices subindustry, Allied Healthcare Products's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Allied Healthcare Products Beneish M-Score Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Allied Healthcare Products's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Allied Healthcare Products's Beneish M-Score falls into.



Allied Healthcare Products Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Allied Healthcare Products for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.0813+0.528 * 2.0964+0.404 * 0.3587+0.892 * 0.7455+0.115 * 1.1325
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.2484+4.679 * -0.064816-0.327 * 0.7562
=-2.56

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Jun22) TTM:Last Year (Jun21) TTM:
Total Receivables was $2.37 Mil.
Revenue was 6.015 + 6.867 + 6.807 + 7.358 = $27.05 Mil.
Gross Profit was 0.444 + 0.44 + 0.707 + 0.937 = $2.53 Mil.
Total Current Assets was $16.08 Mil.
Total Assets was $19.67 Mil.
Property, Plant and Equipment(Net PPE) was $3.36 Mil.
Depreciation, Depletion and Amortization(DDA) was $0.45 Mil.
Selling, General, & Admin. Expense(SGA) was $7.11 Mil.
Total Current Liabilities was $5.98 Mil.
Long-Term Debt & Capital Lease Obligation was $0.00 Mil.
Net Income was -1.935 + -1.28 + -1.162 + -0.984 = $-5.36 Mil.
Non Operating Income was 0 + 0 + 0.01 + 0 = $0.01 Mil.
Cash Flow from Operations was -2.657 + 0.391 + -1.142 + -0.688 = $-4.10 Mil.
Total Receivables was $2.94 Mil.
Revenue was 7.019 + 7.967 + 11.104 + 10.19 = $36.28 Mil.
Gross Profit was 1.188 + 1.435 + 2.612 + 1.874 = $7.11 Mil.
Total Current Assets was $13.39 Mil.
Total Assets was $17.70 Mil.
Property, Plant and Equipment(Net PPE) was $3.74 Mil.
Depreciation, Depletion and Amortization(DDA) was $0.58 Mil.
Selling, General, & Admin. Expense(SGA) was $7.64 Mil.
Total Current Liabilities was $7.11 Mil.
Long-Term Debt & Capital Lease Obligation was $0.01 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(2.37 / 27.047) / (2.94 / 36.28)
=0.087625 / 0.081036
=1.0813

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(7.109 / 36.28) / (2.528 / 27.047)
=0.195948 / 0.093467
=2.0964

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (16.082 + 3.359) / 19.671) / (1 - (13.385 + 3.74) / 17.702)
=0.011692 / 0.032595
=0.3587

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=27.047 / 36.28
=0.7455

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(0.579 / (0.579 + 3.74)) / (0.451 / (0.451 + 3.359))
=0.134059 / 0.118373
=1.1325

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(7.107 / 27.047) / (7.636 / 36.28)
=0.262765 / 0.210474
=1.2484

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((0.003 + 5.982) / 19.671) / ((0.008 + 7.114) / 17.702)
=0.304255 / 0.402327
=0.7562

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-5.361 - 0.01 - -4.096) / 19.671
=-0.064816

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Allied Healthcare Products has a M-score of -2.56 suggests that the company is unlikely to be a manipulator.


Allied Healthcare Products Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Allied Healthcare Products's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Allied Healthcare Products (Allied Healthcare Products) Business Description

Traded in Other Exchanges
N/A
Address
1720 Sublette Avenue, Saint Louis, MO, USA, 63110
Allied Healthcare Products Inc manufactures a variety of respiratory products used in the healthcare industry in a wide range of hospital and alternate site settings, including sub-acute care facilities, home health care, and emergency medical care. The product line of the company includes respiratory anesthesia products, home respiratory care products, medical gas system construction products, medical gas system regulation devices, disposable oxygen, and specialty gas cylinders, portable suction equipment, trauma, and patient handling products, respiratory products, and others. The company markets its products under various brand names Timeter, Carbolime, Litholyme, Schuco, Chemetron, Oxequip, Lif-O-Gen, Gomco, and others.
Executives
John D Weil director, 10 percent owner 10 S. BROADWAY, SUITE 2000, ST LOUIS MO 63102
Susan M Deuser director 1720 SUBLETTE AVENUE, ST. LOUIS MO 63110
Kevin D Kroupa officer: Vice President of Operations 1720 SUBLETTE AVENUE, ST. LOUIS MO 63110
Earl R Refsland director, officer: President and CEO 1720 SUBLETT AVENUE, ST. LOUIS MO 63110
Joseph F Ondrus officer: Vice President of Operations 1720 SUBLETTE AVENUE, ST. LOUIS MO 63110
Andrew Riley officer: VP of Operations 1720 SUBLETTE AVE., ST. LOUIS MO 63110
William A Peck director 35 CROSBY DRIVE, BEDFORD MA 01730
Daniel C Dunn officer: VP - Finance and CFO 1720 SUBLETTE AVE, ST. LOUIS MO 63110
Eldon P Rosentrater officer: VP - Administration 1720 SUBLETTE AVE, ST. LOUIS MO 63110
Root Joseph Ernest Jr director HAYNES BEFFEL & WOLFELD LLP, 751 KELLY STREET, HALF MOON BAY CA 94019
Robert Bradley Harris officer: Vice President of Operations 15 RIVER RIDGE TRAIL, ORMOND BEACH FL 32174
Judy T Graves director 13317 WESTERMAN RD, ST LOUIS MO 63122
Hickey James B Jr director 4608 EDINA BLVD, EDINA MN 55424
Richard A Setzer officer: VICE PRESIDENT SALES & MKTG 1720 SUBLETTE AVENUE, ST. LOUIS MO 63110
Brent D Baird director 1350 ONE M&T PLAZA, BUFFALO NY 14203-2396